Kohlberg Kravis Roberts & Co. LP has announced an agreement to invest in Catalio Capital Management, LP, a multi-strategy investment firm focused on breakthrough biomedical technology and innovative healthcare companies. The addition of new capital is expected to accelerate Catalio’s growth trajectory and talent acquisition and anchor its investment strategies.
Under the agreement, KKR will acquire a minority economic stake in Catalio and will invest in Catalio’s funds. Henry Kravis, co-founder and co-executive chairman of KKR, has been named chairman of a new board of advisors for Catalio that will help guide the company’s strategic growth. Members of Catalio’s board of advisors include Alex Gorsky, the retired Chairman & CEO of Johnson & Johnson, Andrew Liveris, the retired Chairman & Chief of Dow Chemical Co, Dina Powell McCormick, the Vice Chairman & Chairman of Global Client Services at BDT & MSD, and Tim J. O’Neill, longtime partner and retired co-head of Goldman Sachs Asset Management.